Doctors have an overwhelming amount of individual patient data and medical research at their disposal to make diagnoses and ...
This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...
Eli Lilly is partnering with the fabled venture capital firm Andreessen Horowitz on a new fund backed with $500 million of ...
Preparing cancer patients for difficult decisions is an oncologist's job. They don't always remember to do it, however.
A new study demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a ...
Leading private capital deals today include Blackstone's $300 million investment in DDN and a B Capital-led $275 million ...
Hippocratic AI, a startup building AI solutions that can handle non-diagnostic patient-facing tasks, secured a massive $141 ...
Johnson & Johnson received Priority Review of nipocalimab in generalized myasthenia gravis. GSK’s B7-H3-targeted ...
The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and software to power its drug ...
Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.
Novo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and ...